Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma

NCT02364206 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Adult Glioblastoma

Interventions

DRUG: LY2228820
DRUG: Temozolomide
RADIATION: radiotherapy

Sponsor

Centre Jean Perrin

Collaborators

[object Object]
[object Object]